Immunotoxic effects of TCDD and toxic equivalency factors

Teratogenesis Carcinogenesis and Mutagenesis

Volumn 17, Issue 4-5, 1997, Pages 275-284

  Vos, Joseph G ^a,b   De Heer, Cees ^c   Van Loveren, Henk ^a  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

^c UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Human risk assessment; Immunosuppression; Impaired host resistance; PCB, PCDF, SCID mouse; TCDD; Thymic epithelium; Thymus toxicity

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; POLYCHLORINATED DIBENZOFURAN;

CONFERENCE PAPER; HOST RESISTANCE; HUMAN; IMMUNITY; IMMUNOTOXICITY; NETHERLANDS; PRIORITY JOURNAL; RISK ASSESSMENT; THYMUS ATROPHY;

EID: 0031409350     PISSN: 02703211     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1520-6866(1997)17:4/5<275::AID-TCM10>3.0.CO;2-B     Document Type: Conference Paper

References (48)

1. Rappe C, Buser HR: In Kimbrough RD, Jensen AA: "Halogenated Biphenyls, Terphenyls, Naphthalenes, Dibenzodioxins and Related Products." Amsterdam: Elsevier, 1989, pp 47-71.
2. Safe S: Polychlorinated biphenyls (PCBs), dibenzo-p-dioxins (PCDDs), dibenzofurans (PCDFs) and related compounds. Environmental and mechanistic considerations which support the development of toxic equivalence factors (TEFs). CRC Crit Rev Toxicol 21:51-87, 1990.
3. Neubert D, Golor G, Hagenmaier H: Toxic TCDD equivalents, problems and applicability for risk assessment. In: "Health Effects and Safety Assessment of Dioxins and Furans." Washington DC: The Toxicology Forum Inc., 1990, p 560.
4. Vos JG, Luster MI: Immune alterations. In Kimbrough RD, Jensen AA: "Halogenated Biphenyls, Terphenyls, Naphthalenes, Dibenzodioxins and Related Products." Amsterdam: Elsevier, 1989, pp 295-322.
5. Nebert DW, Jensen NM, Perry JW, Oka T: Association between ornithine decarhoxylase induction and the Ah locus in mice treated with polycyclic aromatic compounds. J Biol Chem 255:6836-6842, 1980.
6. Kerkvliet NI, Baecher-Steppan L, Henderson MC, Buhler DR: Role of the Ah locus in TCDD immunotoxicity: Studies in C57B1/6 mice congenic at the Ah locus. Toxicologist 9:39, 1989.
7. Carlstedt-Duke JMB: Tissue distribution of the receptor for 2,3,7,8-tetrachlorodibenzo-p-dioxin in the rat. Cancer Res 39:3172-3176, 1979.
8. Poland A, Glover E: 2,3,7,8-Tetrachlorodibenzo-p-dioxin: Segregation of toxicity with the Ah receptor. Mol Pharmacol 17:86-94, 1980.
9. Greenlee WF, Dold KM, Irons RD, Osborne A: Evidence of direct action of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on thymic epithelium. Toxicol Appl Pharmacol 79:112-120, 1985.
10. Cook JC, Dold KM, Greenlee WF: An in vitro model for studying the toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin to human thymus. Toxicol Appl Pharmacol 89:256-268, 1987.
11. Nagarkatti PS, Sweeney GD, Gauldie J, Clark DA: Sensitivity to suppression of cytotoxic T cell generation by 2,3,7,8-tetrachlorodibenzo-p-dioxin is dependent on the Ah genotype of the murine host. Toxicol Appl Pharmacol 72:169-176, 1984.
12. De Waal EJ, Rademakers LHPM, Schuurman HJ, Van Loveren H, Vos JG: Atrophy of the rat thymus. In: Imhof BA, Berri-Aknin S, Ezine S: "Lymphatic Tissues and In Vivo Immune Responses." New York: Marcel Dekker Inc., 1991, pp 117-121.
13. De Waal EJ, Schuurman HJ, Loeber JG, Van Loveren H, Vos JG: Alterations in the cortical thymic epithelium of rats after in vivo exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD): An (immuno)histological study. Toxicol Appl Pharmacol 115:80-88, 1992.
14. 1 levels in persons exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin. J Toxicol Environ Health 28:285-295, 1989.
15. 2+-mediated endonuclease activation. Science 242:256-259, 1988.
16. De Heer C, Verlaan APJ, Penninks AH, Vos JG, Schuurman HJ, Van Loveren H: Time course of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-induced thymic atrophy in the Wistar rat. Toxicol Appl Pharmacol 128:97-104, 1994.
17. Blaylock BL, Holladay SD, Comment CE, Heindel JJ, Luster MI: Exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) alters fetal thymocyte maturation. Toxicol Appl Pharmacol 112:207-213, 1992.
18. Fine JS, Silverstone AE, Gasiewicz TA: Impairment of prothymocyte activity by 2,3,7,8-tetrachlorodibenzo-p-dioxin. J Immunol 144:1169-1176, 1990.
19. Van Loveren H, Schuurman HJ, Kampinga J, Vos JG: Reversibility of thymic atrophy induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and bis(tri-n-butyltin)oxide (TBTO). Int J Immunopharmacol 13:369-377, 1991.
20. Neubert R, Jacob-Müller U, Stahlmann R, Helge H, Neubert D: Polyhalogenated dibenzo-ρ-dioxins and dibenzofurans and the immune system. 1. Effects on peripheral lymphocyte subpopulations of a non-human primate (Callithrix jacchus) after treatment with 2,3,7,8-tetrachlorodibenzo-ρ-dioxin (TCDD). Arch Toxicol 64:345-359, 1990.
21. Neubert R, Jacob-Müller U, Helge H, Stahlmann R, Neubert D: Polyhalogenated dibenzo-ρ-dioxins and dibenzofurans and the immune system. 2. In vitro effects of 2,3,7,8-tetrachlorodibenzo-ρ-dioxin (TCDD) on lymphocytes of venous blood from man and a non-human primate (Callithrix jacchus). Arch Toxicol 65:213-219, 1991.
22. Tucker AN, Vore SJ, Luster MI: Suppression of B cell differentiation by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Mol Pharmacol 29:372-377, 1986.
23. Luster MI, Germolec DR, Clark G, Wiegand G, Rosenthal GJ: Selective effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin and corticosteroid on in vitro lymphocyte maturation. J Immunol 140:928-935, 1988.
24. Holsapple MP, Snyder NK, Wood SC, Morris DL: A review of 2,3,7,8-tetrachlorodibenzo-ρ-dioxin-induced changes in immunocompetence: 1991 update. Toxicology 69:219-251, 1991.
25. Vos JG, Van Loveren H, Schuurman H-J: Immunotoxicity of dioxin: immune function and host resistance in laboratory animals and humans. In Gallo MA, Scheuplein RJ, Van Der Heijden KA: "Biological Basis for Risk Assessment of Dioxins and Related Compounds." Banbury Report 35. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1991, pp. 79-93.
26. Clark GC, Taylor MJ, Tritscher AM, Lucier GW: Tumor necrosis factor involvement in 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) mediated endotoxin hypersensitivity in C57B1/6 mice congenital the Ah locus. Toxicol Appl Pharmacol 111:442-451, 1991.
27. White KL, Lysy HH, McCay JA, Anderson AE: Modulation of serum complement levels following exposure to polychlorinated dibenzo-p-dioxins. Toxicol Appl Pharmacol 84:209-219, 1986.
28. Reggiani G: Medical problems raised by the TCDD contamination in Seveso, Italy. Arch Toxicol 40:161-168, 1978.
29. Hoffman RE, Stehr-Green PA, Webb KB, Evans G, Knutsen AP, Schramm WF, Staake JL, Gibsob BB, Steinberg KK: Health effects of long-term exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin. JAMA 255:2031-2038, 1986.
30. Evans RG, Webb KB, Knutsen AP, Roodman ST, Roberts DW, Bagby JR, Garrett WA, Andrews JS: A medical follow-up of the health effects of long-term exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Arch Environ Health 43:273-278, 1988.
31. Jennings AM, Wild G, Ward JD, Ward AM: Immunological abnormalities 17 years after accidental exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Br J Ind Med 45:701-704, 1988.
32. Neubert R, Maskow L, Webb J, Jacob-Muller U, Nogueira AC, Delgado I, Helge H, Neubert D: Chlorinated dibenzo-p-dioxins and dibenzofurans and the human immune system. 1. Blood cell receptors in volunteers with moderately increased body burdens. Life Sci 53:1995-2006, 1993.
33. Chang KH, Hsieh KH, Lee TP, Tang SY, Tung TC: Immunologic evaluation of patients with polychlorinated biphenyl poisoning: Determination of lymphocyte subpopulations. Toxicol Appl Pharmacol 61:58-63, 1981.
34. Chang KH, Hsieh KH, Tang SY, Tung TC, Lee TP: Immunologic evaluation of patients with polychlorinated biphenyl poisoning: Evaluation of delayed-type hypersensitivity response and its relation to clinical studies. J Toxicol Environ Health 9:217-223, 1982.
35. Wu YC, Lo YC, Kao HY, Pan CC, Lin RY: Cell-mediated immunity in patients with polychlorinated biphenyl poisoning. J Formoson Med Assoc 83:419-429, 1984.
36. Rogan WJ, Gladen BC, Hung KL, Koong SL, Shih LY, Taylor JS, Wu YC, Yang D, Ragan NB, Hsu CC: Congenital poisoning by polychlorinated biphenyls and their contaminants in Taiwan. Science 241:334-336, 1988.
37. Shigematsu N, Ishimaru S, Saito R, Idea T, Matsuba K, Sugiyama K, Masuda Y: Respiratory involvement in polychlorinated biphenyls poisoning. Environ Res 16:92-100, 1978.
38. Elo O, Vuolojathi P, Janhunen H, Rantanen J: Recent PCB accidents in Finland. Environ Health Perspect 60:315-319, 1985.
39. Lang DS, Becker S, Clark GC, Devlin RB, Koren HS: Lack of direct immunosuppressive effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on human peripheral blood lymphocyte subsets in vitro. Arch Toxicol 68:296-302, 1994.
40. McCune JM, Namikawa R, Kaneshima H, Shultz LD, Lieberman M, Weissman IL: The SCID-hu mouse: Murine model for the analysis of human hematolymphoid differentiation and function. Science 241:1632-1639, 1988.
41. Mosier DE, Gulizia RJ, Baird SM, Wilson DB: Transfer of a functional human immune system to mice with severe combined immunodeficiency. Nature 335:256-259, 1988.
42. Schuler W, Weiler IJ, Schuler A, Phillips RA, Rosenberg N, Mak TW, Kearney JF, Perry RP, Bosma MJ: Rearrangement of antigen receptor genes is defective in mice with severe combined immune deficiency. Cell 46:963-972, 1986.
43. Namikawa R, Weilbaecher KN, Kaneshima H, Yee EJ, McCune JM: Long-term human hematopoiesis in the SCID-hu mouse. J Exp 172:1055-1063, 1990.
44. McCune JM: The SCID-hu mouse: A small animal model for HIV infection and pathogenesis. Annu Rev Immunol 9:399-429, 1991.
45. De Heer C, Schuurman HJ, Djien Liem AK, Penninks AK, Vos JG, Van Loveren H: Toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) to the human thymus after transplantation in SCID mice. Toxicol Appl Pharmacol 134:296-304, 1995.
46. Vos JG, Moore JA, Zinkl JG: Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin on the immune system of laboratory animals. Environ Health Perspect 5:149-162, 1973.
47. Clark DA, Sweeney G, Safe S, Hancock E, Kilburn DG, Gauldie J: Cellular and genetic basis for suppression of cytotoxic T-cell generation by haloaromatic hydrocarbons. Immunopharmacology 6:143-153, 1983.
48. Burleson GR, Lebrec H, Yang YG, Ibanes JD, Pennington KN, Birnbaum LS: Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on influenza virus host resistance in mice. Fundam Appl Toxicol 29:40-47, 1996.